Bristol-myers Squibb Compnay

Keith D Combrink

Nicholas A Meanwell

Rita Civiello

Kuo-Long Yu

Xiangdong Alan Wang

Yi Zhang

Hatice Belgin Gulgeze

Ny Sin

Bradley C Pearce

Brian Lee Venables

Jan Willem Thuring

Zhiwei Yin

Edward H Ruediger

Joseph P Yevich

David W Smith

Andrew D Williams

Christopher W Cianci

Bradley C Pearc

Yaxiong Sun

The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.

Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents

Heterocyclic substituted 2-methyl-benzimidazole antiviral agents

The present invention concerns antiviral compounds, their compositions, and use in the treatment of viral infections. More particularly, the invention provides benzimidazolone derivatives for the treatment of respiratory syncytial virus infection.

Benzimidazolone antiviral agents

The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides imidazopyridine and imidazopyrimidine derivatives (Formula I) for the treatment of respiratory syncytial virus infection.

Imidazopyridine and imidazopyrimidine antiviral agents

A series of novel alkoxypyridin-4-yl and alkoxypyrimidin-4-yl derivatives of indol-3-ylalkylpiperazines of Formula I are intended to be useful agents ##STR1## for alleviation of vascular headache on the basis of their potent affinity and agonist activity at 5-HT1D binding sites.

Antimigraine 4-pyrimidinyl and pyridinyl derivatives of

Growing community of inventors

Wallingford, CT, United States of America

Keith D Combrink